Senior insider sale
CHIEF MEDICAL OFFICER at ENLIVEN THERAPEUTICS, INC. — senior position signals high conviction
$1.10M
25K shares
What this filing means
COLLINS HELEN LOUISE plans to sell 25K shares of ENLIVEN THERAPEUTICS, INC. valued at approximately $1.10M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/19/2026ACC: 0001974158-26-000109
Officer· CHIEF MEDICAL OFFICER
Since Feb 2026
25K
Shares to sell
$1.10M
Approx. market value
15K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Options
N/A
8/9/2022
15KTotal acquired15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/9/2022 | Stock Options N/A | 15K | — |
| Total | 15K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5K
Market value
$251.8K
9/17/2026
—Completed
Units to sell
5K
Market value
$292.9K
8/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
15K
Market value
$559.8K
10/19/2026
Total
Units
25K
Value
$1.10M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/17/2026 | 5K | $251.8K | — | Completed |
8/17/2026 | 5K | $292.9K | — | Completed |
| Planned — Approximate Date | ||||
10/19/2026 | 15K | $559.8K | NASDAQ | Planned |
| Total | 25K | $1.10M | ||